Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Analgesics in

Analgesics in the US

22 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

An ageing population pushes sales of analgesics

Although the elderly population (defined as aged 65 or above) is growing worldwide, a 2018 report from the US Census Bureau drew renewed attention to the elderly population in the US especially: by the year 2035, adults aged 65 or older will outnumber children for the first time in US history. This report came amidst a tumultuous year for US politics, in which the ageing of America was often a topic of political conversation, especially when it came to healthcare reform and the long-term future of entitlement programmes such as Medicare and Social Security.

Wary of side-effects, consumers turn to topical analgesics/anaesthetic

Although sales of systemic analgesics continue to significantly eclipse those of topical analgesics/anaesthetic, the latter increased at an incredible pace between 2017 and 2018 – many times faster than systemic analgesics. The primary appeal of topical analgesics amongst consumers comes from the limited side-effects associated with their use: most are based on natural, botanical ingredients with which consumers are familiar and trust to address their symptoms without causing any physical damage.

Transcutaneous Electrical Nerve Stimulation (TENS) offers new challenges

As more consumers are hesitant to take systemic analgesics, a growing number are looking to move away from medications entirely. For these consumers, TENS devices are seen as the future in terms of the management of chronic pain.

COMPETITIVE LANDSCAPE

Advil maintains its lead despite the competition

Advil maintained its lead in analgesics in 2018, despite the competitive environment in systemic analgesics, benefiting from strong physician recommendations, popularity amongst consumers for menstrual pain relief, and the 2017 release of Advil Liqui-Gel minis; smaller pills for consumers on-the-go. Advil also benefited from a marketing strategy that included the utilisation of Amazon algorithms to educate potential consumers and transition more smoothly to an increasingly digital marketplace; doing this better than many of its competitors.

Tylenol’s strong growth leads to the decline of Aleve

Despite Advil’s strong lead in ibuprofen, acetaminophen saw by far the fastest growth within systemic analgesics in 2018, driven almost entirely by Tylenol from McNeil Consumer Healthcare (Johnson & Johnson). Tylenol benefits from several popular brand extensions, as well as a strong marketing presence which emphasises safety for both adults and children.

Biofreeze drives growth in topical analgesics/anaesthetic

Topical analgesics/anaesthetic represents one of the most competitive categories within OTC products, with key brands such as Icy Hot (Chattem/Sanofi), Salonpas (Hisamitsu America) and Biofreeze (Performance Health/Hygienic Corporation) vying for the top spot in terms of both growth and sales. Although Icy Hot continued to lead in 2018, due to line extensions and consumer familiarity, virtually all brands active in topical analgesics/anaesthetic saw significant growth over 2017-2018, with no growth more pronounced than that of Biofreeze, a brand that transitioned from chiropractors’ offices and hospitals to bricks-and-mortar stores in 2016.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in USA market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in USA?
What are the major brands in USA?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in the US - Category analysis

HEADLINES

PROSPECTS

An ageing population pushes sales of analgesics

Wary of side-effects, consumers turn to topical analgesics/anaesthetic

Transcutaneous Electrical Nerve Stimulation (TENS) offers new challenges

COMPETITIVE LANDSCAPE

Advil maintains its lead despite the competition

Tylenol’s strong growth leads to the decline of Aleve

Biofreeze drives growth in topical analgesics/anaesthetic

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Players innovate to follow consumers’ changing lifestyles

Positive growth in 2018, although at a slower pace

A fragmented competitive environment

The move towards internet retailing

Continued growth for consumer health, despite maturity and concern about changes

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Analgesics in the US

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

An ageing population pushes sales of analgesics

Wary of side-effects, consumers turn to topical analgesics/anaesthetic

Transcutaneous Electrical Nerve Stimulation (TENS) offers new challenges

COMPETITIVE LANDSCAPE

Advil maintains its lead despite the competition

Tylenol’s strong growth leads to the decline of Aleve

Biofreeze drives growth in topical analgesics/anaesthetic

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in the US - Category analysis

HEADLINES

PROSPECTS

An ageing population pushes sales of analgesics

Wary of side-effects, consumers turn to topical analgesics/anaesthetic

Transcutaneous Electrical Nerve Stimulation (TENS) offers new challenges

COMPETITIVE LANDSCAPE

Advil maintains its lead despite the competition

Tylenol’s strong growth leads to the decline of Aleve

Biofreeze drives growth in topical analgesics/anaesthetic

CATEGORY DATA

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Players innovate to follow consumers’ changing lifestyles

Positive growth in 2018, although at a slower pace

A fragmented competitive environment

The move towards internet retailing

Continued growth for consumer health, despite maturity and concern about changes

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements (VDS) registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports